A summary of the molecular testing recommended in acute myeloid leukemia

R. Stuckey,Cristina Bilbao-Sieyro,María Teresa Gómez Casares,Roopa Bijja

A summary of the molecular testing recommended in acute myeloid leukemia

2020

R. Stuckey
Cristina Bilbao-Sieyro
María Teresa Gómez Casares
Roopa Bijja

Advances in Next-Generation Sequencing technologies (NGS) are revealing germline and somatic mutations that, together with karyotype, determine the diagnosis and subtype of Acute Myeloid Leukemia (AML).

Keywords:

Cancer research
Somatic cell
Germline
Biology
Myeloid leukemia
Karyotype
heterogeneous group
Oncology
genetic risk
Internal medicine
Midostaurin
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations